HOME >> BIOLOGY >> NEWS
Device that rapidly detects nerve agents named one of 'greatest army inventions' for 2003

PITTSBURGH, June 22 Pittsburgh-based Agentase, LLC's Nerve Agent Sensor was named one of the 10 "Greatest Army Inventions" of the past year by the U.S. Army Research, Development and Engineering Command. The Sensor is a hand-held device that rapidly changes color in the presence of a contaminant such as sarin, one of many nerve agents that are feared to be used in chemical warfare or terrorist attack. The invention is based on research performed by Alan J. Russell, Ph.D., professor of surgery and professor of petroleum and chemical engineering at the University of Pittsburgh, and was funded by the U.S. Army Research Laboratory and the Defense Threat Reduction Agency (DTRA).

The team being recognized includes Dr. Russell, who also is director of the University of Pittsburgh's McGowan Institute for Regenerative Medicine; Stephen J. Lee, Ph.D., and Robert Campbell, Ph.D., both of the U.S. Army Research Office, a part of the U.S. Army Research Laboratory; Larry Pollack of DTRA; and Keith LeJeune, Ph.D., a former student of Dr. Russell's and chief executive officer of Agentase, which he and Dr. Russell co-founded. They will receive the award at a ceremony June 23 at the Hilton McLean Tysons Corner in McLean,Va.

Dr. Russell's research has focused on the interface between enzymes and materials like polymers. As such, the Agentase Nerve Agent Sensor makes use of the pH-dependent catalytic activity of enzymes that have been embedded in a polymer sponge-like material. If contamination is detected, within seconds the sponge changes color from yellow to red.

Beyond its high sensitivity to nerve agents, the Nerve Agent Sensor also is resistant to environmental factors, such as high temperatures, and interference from other compounds. It has a two- to three-year shelf life and is compatible with all testing surfaces. The sensor already is in use in Iraq.

Nominations for the U.S. Army Greatest Inventions Program were submitted from across the Army
'"/>


22-Jun-2004


Page: 1 2

Related biology news :

1. Tiny tango: Device sorts microscopic particles with speed and precision
2. Device detects, traps and deactivates airborne viruses and bacteria
3. Device liberates quadriplegic from ventilator
4. Growing Up On Their Own: Smart Plastics Organize Themselves Into Useful Optical Devices
5. New Rehabilitative Device Combines Form And Function For Children With Mobility Impairments
6. New Device Brightens Recycling Efforts
7. New Device To Alleviate Distress Caused By Tinnitus
8. University of Kentucky Neuroscientist Develops Unique Device For Treatment Of Brain Tumors
9. Penn Researchers Invent Worlds First Device To Rapidly Assess Lung Function
10. Circulatory Device -- A Bridge To Recovery For Heart Failure?
11. UPMC Reports On New Liver Assist Device

Post Your Comments:
(Date:5/17/2013)... noise of the South, but the night belongs to the ... heavy from the humidity and the sounds of wildlife. ... frogs, toads and salamanders, is the center of amphibian biodiversity ... the auditorium for their symphonic choruses, the scientists of the ... have front-row seats. , Amphibians, which rely on ...
(Date:5/17/2013)... ages will celebrate the science and technology of ... lives during the inaugural Atlanta Science Festival, March ... local museums, corporations, K-12 schools and universities, the ... for children and adults at venues across the ... , The annual Atlanta Science Festival is a ...
(Date:5/17/2013)... Shenzhen, China---- Why Tibetan antelope can live at ... a collaborative research published in Nature Communications ... institutes provide evidence that some genetic factors may ... highland environments. The data in this work will ... and the biology of other ruminant species. , ...
Breaking Biology News(10 mins):Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4First Atlanta Science Festival set for 2014 2The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2
(Date:5/20/2013)... , May 20, 2013 Today, at ... San Francisco , James McGough ... Psychiatry at the Semel Institute for Neuroscience and Human ... of Medicine at the University of California Los Angeles ... Child and Adolescent Psychopharmacology and ADHD at UCLA, presented ...
(Date:5/20/2013)... Biomarkers and Clinigene International are set to unveil their ... 2013 AAPS/ National Biotechnology Conference May 20-22 ... Marina , San Diego, CA. ... company representatives at their collaborative seminar, "Biosimilarity, Immunogenicity and ... 1-2 p.m. in the conference,s Spinnaker Room. ...
(Date:5/20/2013)... 2013 Cempra, Inc. (Nasdaq: CEMP), a ... to meet critical medical needs in the treatment ... data at the American Thoracic Society International Conference ... demonstrating the antibacterial and enhanced immunomodulatory activity of ... clinical trial in outpatients with community acquired bacterial ...
(Date:5/20/2013)... 2013 Interventional cardiologist Tony Farah, MD, ... (AGH) Cardiovascular Institute have helped pioneer many breakthroughs ... (CAD) over the past three decades, from new ... and coronary artery stent implantation. , Today, AGH officials ... prominent role in the study of a novel, first-of-its ...
Breaking Biology Technology:Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4
Cached News: